Inventor · disambiguated record
Michael Stocks
Also filed as: STOCKS MICHAEL · STOCKS MICHAEL JOHN
10 granted patents·14 pending applications·115 citations·filing 1996–2023
89Inventor score
Files withASTRAZENECA AB9KALVISTA PHARMACEUTICALS LTD5BAXTER ANDREW2JAGUAHR THERAPEUTICS PTE LTD2ALCARAZ LILIAN1
Top patents by PatentIndex Score
24 records- 0188US9533987B2Heterocyclic derivatesKALVISTA PHARMACEUTICALS LTD·Filed 2014·Granted Jan 3, 2017·19 cites·27 claims
- 0283US7709511B2Benzothiazolone derivativesASTRAZENECA AB·Filed 2006·Granted May 4, 2010·8 cites·6 claims
- 0382US7129246B2N-adamantlmethyl derivatives and intermediates as pharmaceutical compositions and processes for their preparationASTRAZENECA AB·Filed 2002·Granted Oct 31, 2006·20 cites·19 claims
- 0473US6265409B1Pyridine derivatives and pharmaceutical compositions containing themASTRAZENECA AB·Filed 1998·Granted Jul 24, 2001·19 cites·5 claims
- 0570US7410972B2CompoundsASTRAZENECA AB·Filed 2002·Granted Aug 12, 2008·6 cites·16 claims
- 0669US2023250080A1Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2023·Application pending·0 cites
- 0768US6300352B1Pyridine derivatives and pharmaceutical compositions containing themASTRAZENECA AB·Filed 1998·Granted Oct 9, 2001·29 cites·10 claims
- 0864US11613527B2Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2021·Granted Mar 28, 2023·0 cites·46 claims
- 0962US7662825B2N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseasesASTRAZENECA AB·Filed 2003·Granted Feb 16, 2010·1 cites·14 claims
- 1058US2010081670A1N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseasesBAXTER ANDREW·Filed 2009·Application pending·0 cites
- 1154US2024059691A1Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 1250US2009018133A1Novel Adamantane DerivativesFORD RHONAN·Filed 2008·Application pending·0 cites
- 1349US2025129092A1Compounds useful in modulation of ahr signallingJAGUAHR THERAPEUTICS PTE LTD·Filed 2022·Application pending·0 cites
- 1447US6143751APyridine derivatives and pharmaceutical compositions containing themASTRAZENECA UK LTD·Filed 1998·Granted Nov 7, 2000·9 cites·11 claims
- 1547US2009029958A1Phenethanolamine derivatives as beta2 adrenoreceptor agonistsALCARAZ LILIAN·Filed 2007·Application pending·0 cites
- 1646US2005090524A1Novel adamantane derivativesFiled 2003·Application pending·0 cites
- 1746US2007093491A1Novel condensed n-pyrazinyl-sulphonamides and their use in the treament of chemokine mediated diseasesBAXTER ANDREW·Filed 2004·Application pending·0 cites
- 1845US2009233965A1Alkyl Esters Of Cyclic Amino Alcohols With Muscarinic M3 Receptor Antagonist Activity, Useful For Treating E.G. Chronic Bronchial Obstruction, Asthma And Overactive BladderASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 1945US2023279000A1Pyridopyrimidine derivatives useful in modulation of ahr signallingJAGUAHR THERAPEUTICS PTE LTD·Filed 2021·Application pending·0 cites
- 2044US2009221653A17-(2-amino-1-hydroxy-ethyl)-4-hydroxybenzothiazol-2(3H)-one-derivatives as beta2 adrenoreceptor agonistsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2143US2022298138A1Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
- 2241US2009203753A17-(2-amino-1-hydroxy-ethyl)-4-hydroxybenzothiazol-2(3H)-one-derivatives as beta2 adrenoreceptor agonistsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2335US5977105ACompoundsASTRA PHARMAEUTICALS LTD·Filed 1996·Granted Nov 2, 1999·4 cites·14 claims
- 2433US2010210688A1Novel Benzothiazolone DerivativesBONNERT ROGER·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Stocks files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →